Ipragliflozin Exerts Anti-Fibrotic Effects via a Novel Multi-Pathway Mechanism: Targeting TLR4/NF-κB /TGF-β1 Cascade
{{output}}
Hepatic fibrogenesis represents a significant and escalating global health challenge with few effective treatments. This research explored the anti-fibrotic potential of the sodium-glucose cotransporter 2 (SGLT2) inhibitor Ipragliflozin (IPRA) in a rat model o... ...
